Effect of hyperacute immunotherapy in addition to standard adjuvant therapy for resected pancreatic cancer on disease-free and overall survival: Preliminary analysis of phase II data. Background: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results